Home›Cardiology› Implantable cardiac monitors detect 21.3% prevalence of atrial fibrillation in post-stroke patients
Implantable cardiac monitors detect 21.3% prevalence of atrial fibrillation in post-stroke patientsDifferent Monitoring Methods Show Varying Rates of Atrial Fibrillation
International journal of stroke : official journal of the International Stroke SocietyPublished August 1, 2026Study authors: Ababneh Ghassab E, Yassin Ahmed, Allahham Malik, Alawneh Khaled, Hamed Suhyb, Alomari Sohaib A, Jara…PubMed ↗DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Note that implantable cardiac monitors detect a higher prevalence of atrial fibrillation (21.3%) than other monitoring methods.
This meta-analysis synthesizes data from 91 studies regarding the prevalence of atrial fibrillation detected after stroke or transient ischemic attack (AFDAS) and 54 studies identifying predictors for this condition. The analysis evaluates various monitoring modalities, including emergency room ECG, inpatient ECG, continuous ECG monitoring, external loop recording, Holter monitors, and implant other methods.
Results indicate significant variation in detection rates based on the method used. Implantable cardiac monitors showed a prevalence of 21.3% (95% CI 18.3-24.7), while multiple monitoring methods yielded a prevalence of 17.2% (95% CI 10-28.1). Other methods reported lower rates: continuous ECG (11.9%), external loop recording (11.5%), inpatient ECG (12.7%), emergency room ECG (7%), and Holter monitors (5.1%).
Several factors were associated with increased AF detection, including older age, female sex, hypertension, chronic kidney disease, left atrial enlargement, advanced interatrial block, higher NIHSS scores, insular involvement, major strokes, and elevated NT-proBNP and BNP levels. These findings suggest that identifying patients with these specific markers can optimize screening strategies to facilitate earlier anticoagulation. The study notes that these predictors are associated with detection rather than causal.
How this fits prior evidence
This meta-analysis addresses a gap in understanding the prevalence of atrial fibrillation following stroke or transient ischemic attack by comparing various monitoring modalities. While prior coverage has focused on the management of patients with known atrial fibrillation, such as those undergoing pulsed field ablation or managing anticoagulation in cirrhosis, this study provides specific data on detection rates using different technologies like implantable cardiac monitors.
Researchers analyzed 91 studies to determine how often atrial fibrillation (AF) is detected in patients following a stroke or transient ischemic attack. The results showed that different monitoring methods yield different detection rates. For example, emergency room ECGs found AF in about 7% of cases, while implantable cardiac monitors showed a much higher rate of 21.3%.
Other tools like Holter monitors and external loop recordings showed similar results, with detection rates around 5% to 11.5%. Continuous monitoring also showed a rate of 11.9%. These differences suggest that the type of equipment used can significantly impact how many patients are identified as having an irregular heart rhythm.
Several factors were linked to a higher chance of detecting atrial fibrillation, including older age, being female, and having high blood pressure or kidney disease. Because these findings come from a meta-analysis of various studies, they show links rather than certain causes. Patients should talk to their doctors about which monitoring methods are best for their specific situation.
What this means for you:
Different heart monitoring tools show different rates of atrial fibrillation detection after a stroke or TIA.
Common questions
How does the type of monitor affect results?
The method used to check for atrial fibrillation makes a difference. For example, emergency room ECGs found a 7% prevalence rate, while implantable cardiac monitors showed a much higher rate of 21.3%. Other methods like Holter monitors and external loop recordings showed rates between 5.1% and 11.5%.
Who is at higher risk for atrial fibrillation after a stroke?
Several factors are associated with an increased detection of atrial fibrillation. These include being older, being female, having hypertension, chronic kidney disease, and having certain heart or lung markers like elevated NT-proBNP levels.
What does this mean for stroke patients?
Identifying high-risk factors can help doctors choose the best screening strategy. This may help start early treatment to reduce the risk of another stroke. You should discuss these specific monitoring options with your healthcare provider.
BACKGROUND: Atrial fibrillation (AF) detected after stroke or transient ischemic attack (AFDAS) is a critical but often underdiagnosed condition with implications for secondary stroke prevention. This distinctive type of AF is increasingly studied to provide a more comprehensive understanding of its complex pathophysiology, which may involve both cardiogenic mechanisms and stroke-induced autonomic dysfunction, a concept known as the neurogenic hypothesis. This study aims to identify the prevalence and predictors of AFDAS to help refine monitoring strategies and improve patient outcomes.
METHODS: We conducted a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We included English-language retrospective and prospective cohort studies published from January 1999 to January 2025, analyzing data from 91 studies for prevalence and 54 studies for predictors. We categorized AF detection by different monitoring methods, including electrocardiogram (ECG), Holter monitoring, external loop recorders, and implantable cardiac monitors (ICM). Predictors were grouped into demographic, cardiogenic, neurogenic, and laboratory factors.
RESULTS: The overall prevalence of AFDAS varied significantly based on monitoring technique. The pooled prevalence was 7% (95% CI 4.6-10.5) by emergency room ECG, 12.7% (95% CI 9-17.8) by inpatient ECG, 11.9% (95% CI 7.8-17.9) by continuous ECG monitoring, 11.5% (95% CI 8-16.1) by external loop recording, 5.1% (95% CI 2.6-9.7) by Holter monitor, 21.3% (95% CI 18.3-24.7) by ICM, and 17.2% (95% CI 10-28.1) by multiple monitoring methods. Key predictors of AFDAS included older age, female sex, hypertension, chronic kidney disease, left atrial enlargement, advanced interatrial block, and higher NIHSS scores. Insular involvement and major strokes were strongly associated with AF detection, supporting the neurogenic hypothesis. Elevated N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) and B-type Natriuretic Peptide (BNP) levels were also linked to a higher AF risk.
CONCLUSION: AFDAS is a frequent but variably detected condition, with its prevalence strongly dependent on monitoring duration and modality. Identifying high-risk patients using a combination of clinical, cardiogenic, neurogenic, and laboratory markers can optimize screening strategies and early anticoagulation initiation, potentially reducing stroke recurrence. Future research should focus on refining risk scores integrating neurogenic and cardiogenic markers to guide personalized monitoring approaches and to define the distinct characteristics of AFDAS from known atrial fibrillation (KAF).
